Delivery Platforms
Oral Sprays

Oral Sprays

Innovative metered dose oral spray that will precisely dose cannabis extractions, to the oromucousal lining as the root of administration, this will prevent excess medication in the intestinal tract.

Metered dose dispenser with child-proof locking mechanism

Topical Oils

Topical Oils

Our topicals are packaged in sachets that deliver the best possible metered dose for pharmaceutical applications

One hand opening unit dose

comfort

comfort

Chronic Pain Relief Formulation: Topical monodose and metered dose oral spray formats

Dosecann is presently formulating a monodose topical application and an innovative metered dose oral spray formulation for patients that have chronic pain throughout various parts of the body. Diseases like Rheumatoid arthritis, fibromyalgia and multiple sclerosis to name a few require a medication that enters the body and circulates the blood stream to reach all areas of the body. Using our revolutionary metered dose spray will allow penetration in the mouth and prevent excess medication in the intestinal tract.

Neuropathic Pain formulation: Topical monodose and metered dose oral spray formats

Nerve pain is described as continuous or intermittent spontaneous pain with severe symptoms of burning, tingling and electric shock-like pain. Nerve pain can be characterized by an peripheral neuropathy, diabetic neuropathy, shingles, trigeminal neuralgia and others. The prevalence of nerve pain is between 6-8% globally – making it a significant world problem. Dosecann is presently formulating a monodose topical application for specific targeted areas and an innovative metered dose oral spray formulation for patients that have chronic nerve pain throughout various parts of the body.

Acute Pain Relief formulation: Topical monodose format

Dosecann is presently formulating a pain cream reliever that consists of an innovative cannabis formulation containing a specific ratio profile of THC, CBD, CBC, CBN, terpenes and bioflavonoids that will be target specific for the patients inflicted with acute pain due to inflammation and trauma. This formulation will be provided in a topical monodose format, allowing the topical oil formulation to specifically penetrate at the local level of the pain – preventing high exposure to systemic circulation in the body.

Chronic Pain Relief Formulation: Topical monodose and metered dose oral spray formats

Dosecann is presently formulating a monodose topical application and an innovative metered dose oral spray formulation for patients that have chronic pain throughout various parts of the body. Diseases like Rheumatoid arthritis, fibromyalgia and multiple sclerosis to name a few require a medication that enters the body and circulates the blood stream to reach all areas of the body. Using our revolutionary metered dose spray will allow penetration in the mouth and prevent excess medication in the intestinal tract.

Neuropathic Pain formulation: Topical monodose and metered dose oral spray formats

Nerve pain is described as continuous or intermittent spontaneous pain with severe symptoms of burning, tingling and electric shock-like pain. Nerve pain can be characterized by an peripheral neuropathy, diabetic neuropathy, shingles, trigeminal neuralgia and others. The prevalence of nerve pain is between 6-8% globally – making it a significant world problem. Dosecann is presently formulating a monodose topical application for specific targeted areas and an innovative metered dose oral spray formulation for patients that have chronic nerve pain throughout various parts of the body.

Acute Pain Relief formulation: Topical monodose format

Dosecann is presently formulating a pain cream reliever that consists of an innovative cannabis formulation containing a specific ratio profile of THC, CBD, CBC, CBN, terpenes and bioflavonoids that will be target specific for the patients inflicted with acute pain due to inflammation and trauma. This formulation will be provided in a topical monodose format, allowing the topical oil formulation to specifically penetrate at the local level of the pain – preventing high exposure to systemic circulation in the body.

relax

relax

Generalized anxiety disorder (GAD) formulation: metered dose oral spray formats

GAD is a prevalent and disabling mental disorder described by persistent worrying, anxiety symptoms, and tension. It is the most frequent anxiety disorder, with it being present in 22% of primary care patients who complain of anxiety problems, and has prevalence of 8% world-wide. GAD is associated with a significant economic burden owing to decreased work productivity and increased use of health care services, particularly primary health care. Dosecann is presently working on a standardized Cannabis formulation that will be dispensed in a metered dose oral spray and relieve the patient’s anxiety.

dream

dream

Sleep formulation: Metered dose oral spray format

Dosecann is presently formulating an oral spray formulation that is safe, non-habit forming, and improves sleep quality by increasing total sleep time. While this product line is amenable to treating jet lag, we hypothesize its applicability towards occasional and chronic insomnia. Approximately 40% of adults report at least one symptom of insomnia three times per week, with 20% being dissatisfied with their sleep and 10-13% meeting the criteria for an insomnia disorder. This high prevalence rate is reflected in the marketplace, with sleep aids generating (in Canada) $97 million in sales in 2016 and expected to grow by ~6% year-over-year. Dosecann’s metered dose spray represents a new and unique player within an innovation-stagnant market.

More innovative products on the horizon

More innovative products on the horizon